Literature DB >> 35834158

The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure.

Anna I Mishkina1, Victor V Saushkin1, Tariel A Atabekov2, Svetlana I Sazonova1, Vladimir V Shipulin1, Samia Massalha3, Roman E Batalov2, Sergey V Popov2, Konstantin V Zavadovsky4.   

Abstract

BACKGROUND: Impaired cardiac sympathetic activity and mechanical dyssynchrony (MD) are associated with poor prognosis in patients with heart failure (HF) after cardiac resynchronization therapy (CRT). The study aims to assess the significance of scintigraphic evaluation of cardiac sympathetic innervation and contractility in predicting response to CRT in patients with ischemic and non-ischemic chronic HF. METHODS AND
RESULTS: The study includes 58 HF patients, who were referred for CRT. Prior to CRT all patients underwent 123I-metaiodobenzylguanidine (123I-MIBG) imaging and gated myocardial perfusion imaging (MPI) using a cadmium-zinc-telluride (CZT) SPECT/CT device. At a one-year follow-up post-CRT, the delayed heart-to-mediastinum 123I-MIBG uptake ratio was an independent predictor of CRT response in non-ischemic HF patients (OR 1.469; 95% CI 1.076-2.007, p = .003). In ischemic HF patients the MD index histogram bandwidth (HBW) obtained by CZT-gated MPI had a predictive value (OR 1.06, 95% CI 1.001-1.112, p = .005) to CRT response.
CONCLUSION: CRT response can be predicted by cardiac 123I-MIBG scintigraphy, specifically by the heart-to-mediastinum ratio in non-ischemic HF and by the MD index HBW in ischemic HF. These results suggest the value of a potentially useful algorithm to improve outcomes in HF patients who are candidates for CRT.
© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.

Entities:  

Keywords:  Heart failure; MPI; cardiac innervation; dyssynchrony; gated SPECT

Year:  2022        PMID: 35834158     DOI: 10.1007/s12350-022-03046-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  50 in total

1.  Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Authors:  Anthony S L Tang; George A Wells; Mario Talajic; Malcolm O Arnold; Robert Sheldon; Stuart Connolly; Stefan H Hohnloser; Graham Nichol; David H Birnie; John L Sapp; Raymond Yee; Jeffrey S Healey; Jean L Rouleau
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

2.  Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.

Authors:  John G F Cleland; Nick Freemantle; Erland Erdmann; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi; Jean-Claude Daubert
Journal:  Eur J Heart Fail       Date:  2012-05-02       Impact factor: 15.534

Review 3.  Adrenergic nervous system in heart failure.

Authors:  M Esler; D Kaye; G Lambert; D Esler; G Jennings
Journal:  Am J Cardiol       Date:  1997-12-04       Impact factor: 2.778

4.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Authors:  Arnold F Jacobson; Roxy Senior; Manuel D Cerqueira; Nathan D Wong; Gregory S Thomas; Victor A Lopez; Denis Agostini; Fred Weiland; Harish Chandna; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2010-02-25       Impact factor: 24.094

5.  Prediction of appropriate ICD therapy in patients with ischemic heart failure.

Authors:  Svetlana I Sazonova; Tariel A Atabekov; Roman E Batalov; Anna I Mishkina; Julia V Varlamova; Konstantin V Zavadovsky; Sergey V Popov
Journal:  J Nucl Cardiol       Date:  2020-08-26       Impact factor: 5.952

6.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.

Authors:  Andrew Marshall; Andrew Cheetham; Robert S George; Mark Mason; Andrew D Kelion
Journal:  Heart       Date:  2012-09       Impact factor: 5.994

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

Review 8.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.

Authors:  Filippos Triposkiadis; George Karayannis; Grigorios Giamouzis; John Skoularigis; George Louridas; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

9.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Ellen Aagaard Nohr; Ole Dan Jørgensen; Jens Cosedis Nielsen
Journal:  Eur Heart J       Date:  2013-12-17       Impact factor: 29.983

10.  Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation.

Authors:  Anna Teresińska
Journal:  J Nucl Cardiol       Date:  2018-04-25       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.